Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Velculescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Papadopoulos N, Cai J, Torbenson MS, Kinzler KW.

Nat Genet. 2011 Aug 7;43(9):828-9. doi: 10.1038/ng.903.

2.

ARID2: a new tumor suppressor gene in hepatocellular carcinoma.

Zhao H, Wang J, Han Y, Huang Z, Ying J, Bi X, Zhao J, Fang Y, Zhou H, Zhou J, Li Z, Zhang Y, Yang X, Yan T, Wang L, Torbenson MS, Cai J.

Oncotarget. 2011 Nov;2(11):886-91. Review.

3.

Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.

Long J, Wang Y, Li M, Tong WM, Jia JD, Huang J.

Oncol Rep. 2013 Jul;30(1):119-24. doi: 10.3892/or.2013.2430. Epub 2013 Apr 26.

PMID:
23624687
4.

Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients.

Fujioka S, Shimomura H, Iwasaki Y, Fujio K, Nakagawa H, Onishi Y, Takagi S, Taniguchi H, Umeoka F, Nakajima H, Moriya A, Nanba K, Piao CY, Shinji T, Koide N, Shiratori Y.

Dig Dis Sci. 2003 Oct;48(10):1920-4.

PMID:
14627334
5.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
6.

Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.

Shieh YS, Nguyen C, Vocal MV, Chu HW.

Int J Cancer. 1993 Jun 19;54(4):558-62.

PMID:
8390407
7.

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.

Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, Peng T, Han ZG, Li LQ.

Liver Int. 2015 Mar;35(3):999-1009. doi: 10.1111/liv.12460. Epub 2014 Jan 27.

PMID:
24461059
8.

Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

Dutta U, Kench J, Byth K, Khan MH, Lin R, Liddle C, Farrell GC.

Hum Pathol. 1998 Nov;29(11):1279-84.

PMID:
9824107
9.

Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.

Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G.

Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.

PMID:
25281206
10.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
11.

Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma.

Song R, Yang B, Gao X, Zhang J, Sun L, Wang P, Meng Y, Wang Q, Liu S, Cheng J.

Mol Med Rep. 2015 Jun;11(6):4053-62. doi: 10.3892/mmr.2015.3256. Epub 2015 Jan 26.

12.

Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.

Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Zhou B, Xiao HS, Qin LX, Han ZG.

Nat Genet. 2012 Oct;44(10):1117-21. doi: 10.1038/ng.2391. Epub 2012 Aug 26.

PMID:
22922871
13.

Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.

Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.

Cancer Res. 2002 Jul 15;62(14):3939-44.

14.

Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G.

Liver Int. 2014 May;34(5):728-36. doi: 10.1111/liv.12313. Epub 2013 Oct 1.

PMID:
24118778
15.

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.

Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.

Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.

PMID:
25203882
16.

P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.

Katiyar S, Dash BC, Thakur V, Guptan RC, Sarin SK, Das BC.

Cancer. 2000 Apr 1;88(7):1565-73.

PMID:
10738214
17.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

18.

Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.

Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T, Sakai Y, Nakamura M, Takatori H, Sunagozaka H, Kaneko S.

Genomics. 2013 Apr;101(4):238-48. doi: 10.1016/j.ygeno.2013.02.007. Epub 2013 Feb 26. Erratum in: Genomics. 2013 Jun;101(6):376.

19.

The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.

Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U.

Int J Cancer. 2012 Mar 15;130(6):1470-5. doi: 10.1002/ijc.26143. Epub 2011 Jun 18.

20.

Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.

Araujo OC, Barros JJ, do Ó KM, Nabuco LC, Luz CA, Perez RM, Niel C, Villela-Nogueira CA, Araujo NM.

J Med Virol. 2014 Feb;86(2):217-23. doi: 10.1002/jmv.23837. Epub 2013 Nov 6.

PMID:
24338810

Supplemental Content

Support Center